ATC
REGN icon

Argent Trust Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Argent Trust Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
1,749
-173
-9% -$118K 0.03% 352
2026
Q1 		$1.49M Buy
1,922
+20
+1% +$15.3K 0.05% 287
2025
Q4 		$1.47M Sell
1,902
-284
-13% -$193K 0.05% 282
2025
Q3 		$1.23M Buy
2,186
+136
+7% +$76.9K 0.04% 305
2025
Q2 		$1.08M Sell
2,050
-96
-4% -$53.6K 0.04% 309
2025
Q1 		$1.36M Sell
2,146
-46
-2% -$31.6K 0.06% 270
2024
Q4 		$1.56M Sell
2,192
-197
-8% -$165K 0.06% 255
2024
Q3 		$2.51M Buy
2,389
+19
+0.8% +$21.1K 0.1% 183
2024
Q2 		$2.49M Buy
2,370
+31
+1% +$30.1K 0.11% 171
2024
Q1 		$2.25M Buy
2,339
+176
+8% +$167K 0.1% 190
2023
Q4 		$1.9M Buy
2,163
+96
+5% +$79.1K 0.09% 196
2023
Q3 		$1.7M Buy
2,067
+91
+5% +$71.5K 0.09% 188
2023
Q2 		$1.42M Buy
1,976
+457
+30% +$352K 0.08% 219
2023
Q1 		$1.25M Sell
1,519
-11
-0.7% -$8.3K 0.08% 210
2022
Q4 		$1.1M Sell
1,530
-39
-2% -$28.8K 0.07% 226
2022
Q3 		$1.08M Buy
1,569
+35
+2% +$22K 0.08% 217
2022
Q2 		$907K Buy
1,534
+21
+1% +$13.7K 0.06% 248
2022
Q1 		$1.06M Sell
1,513
-14
-0.9% -$8.86K 0.06% 241
2021
Q4 		$964K Buy
1,527
+1,173
+331% +$721K 0.06% 263
2021
Q3 		$214K Buy
+354
New +$220K 0.01% 502

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Argent Trust Co's REGN Position: Q2 2026 in Review

Argent Trust Co reduced its Regeneron Pharmaceuticals (REGN) stake by 9% in Q2 2026, selling an estimated $118K and leaving 1,749 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #352.

Argent Trust Co first reported a position in REGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.51M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Argent Trust Co held 1,749 shares of Regeneron Pharmaceuticals worth $1.09M as of Q2 2026.
  • Argent Trust Co sold 173 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $118K.
  • Regeneron Pharmaceuticals made up 0.03% of Argent Trust Co's portfolio in Q2 2026, its #352 holding.
  • Argent Trust Co first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Argent Trust Co's Regeneron Pharmaceuticals position peaked at $2.51M in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.